Notch signaling in leukemia

被引:72
作者
Aster, JC
Pear, WS
机构
[1] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
关键词
D O I
10.1097/00062752-200107000-00010
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Mammalian Notch homologs were first identified from the involvement of Notch I in a recurrent chromosomal translocation in a subset of human T-cell leukemias. The effect of the translocation was twofold: Notch expression was placed under the control of a T-cell-specific element, and Notch was truncated, resulting in a constitutively active protein. Subsequent work has shown that Notch1 is required for T cell commitment and is exclusively oncotropic for T cells. During the past year, several murine models have been used to dissect the function of Notch signaling in lymphoid development and leukemia. These models show that Notch1 drives the earliest stages of T cell commitment and that Notch signaling must be downregulated by the double positive stage for proper T cell development to occur. Constitutive Notch signaling mediated by Notch1, Notch2, or Notch3 predisposes to T-cell leukemia. Future studies are expected to elucidate the mechanisms by which Notch leads to transformation. Identification of the transcriptional targets of Notch signaling is likely to yield important insights. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 68 条
[1]
Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells [J].
Allman, D ;
Karnell, FG ;
Punt, JA ;
Bakkour, S ;
Xu, LW ;
Myung, P ;
Koretzky, GA ;
Pui, JC ;
Aster, JC ;
Pear, WS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (01) :99-106
[2]
Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[3]
Aster JC, 1997, J BIOL CHEM, V272, P11336
[4]
Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1 [J].
Aster, JC ;
Xu, LW ;
Karnell, FG ;
Patriub, V ;
Pui, JC ;
Pear, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7505-7515
[5]
E2A deficiency leads to abnormalities in alpha beta T-cell development and to rapid development of T-cell lymphomas [J].
Bain, G ;
Enel, I ;
Maandag, ECR ;
teRiele, HPJ ;
Voland, JR ;
Sharp, LL ;
Chun, J ;
Huey, B ;
Pinkel, D ;
Murre, C .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (08) :4782-4791
[6]
Beatus P, 1999, DEVELOPMENT, V126, P3925
[7]
Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice [J].
Bellavia, D ;
Campese, AF ;
Alesse, E ;
Vacca, A ;
Felli, MP ;
Balestri, A ;
Stoppacciaro, A ;
Tiveron, C ;
Tatangelo, L ;
Giovarelli, M ;
Gaetano, C ;
Ruco, L ;
Hoffman, ES ;
Hayday, AC ;
Lendahl, U ;
Frati, L ;
Gulino, A ;
Screpanti, I .
EMBO JOURNAL, 2000, 19 (13) :3337-3348
[8]
Notch inhibition of RAS signaling through MAP kinase phosphatase LIP-1 during C-elegans vulval development [J].
Berset, T ;
Hoier, EF ;
Battu, G ;
Canevascini, S ;
Hajnal, A .
SCIENCE, 2001, 291 (5506) :1055-1058
[9]
Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines [J].
Bigas, A ;
Martin, DIK ;
Milner, LA .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :2324-2333
[10]
Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics [J].
Carlesso, N ;
Aster, JC ;
Sklar, J ;
Scadden, DT .
BLOOD, 1999, 93 (03) :838-848